CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis
- 28 July 2022
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 371, 577936
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effect of Connective Tissue Growth Factor on Protein Kinase Expression and Activity in Human Corneal FibroblastsInvestigative Ophthalmology & Visual Science, 2012
- Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-β in human tubular epithelial cellsCell Communication and Signaling, 2012
- Inflammatory Cortical Demyelination in Early Multiple SclerosisNew England Journal of Medicine, 2011
- CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF-κBJournal of the American Society of Nephrology, 2009
- Connective tissue growth factor (CTGF) and cancer progressionJournal of Biomedical Science, 2008
- Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytesJournal of Hepatology, 2007
- Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells––Role of PPAR-γ in vascular fibrosisBiochemical Pharmacology, 2007
- Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathwayAmino Acids, 2006
- Connective Tissue Growth Factor CCN2 Interacts with and Activates the Tyrosine Kinase Receptor TrkAJournal of the American Society of Nephrology, 2005
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002